NYSE American: NNVC
Wattbike acquisition is the latest milestone in transformational strategy and the Sportstech acquisition is on track to close in the third quarter TRNR confirms guidance of more than $75 million in pro forma 2025 revenue and profitability in fourth quarter TRNR’s $55 million Digital Asset Treasury is actively purchasing $FET cryptocurrency AUSTIN, TX AND NOTTINGHAM, […]
SBC Medical (Nasdaq: SBC) Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power
IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) — SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer (CMO), effective July 1, 2025. As CMO of SBC Medical, Mr. Inoue will lead efforts […]
Greenlane (Nasdaq:GNLN) Bolsters Global Sales Effort with Appointment of Mike Hinson as Executive Vice President of Sales
Hinson brings a proven track record of driving growth and innovation in sales organizations BOCA RATON, FL / ACCESS Newswire / June 30, 2025 / Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (Nasdaq:GNLN), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced the appointment of Mike Hinson as the […]
CISO Global (NASDAQ: CISO) Files Significantly Reduced S-3 Shelf Registration
Reaffirms Commitment to Transparency; No Immediate Plans to Utilize ATM or Shelf Registrations Scottsdale, AZ, June 27, 2025 (GLOBE NEWSWIRE) — CISO Global (NASDAQ: CISO), a leader in AI-powered cybersecurity software and compliance services, announced it has filed the renewal of its S-3 shelf registration, reducing the total shelf from $300 million to $100 million. The […]
Updates FAQ in Response to a High Volume of Shareholder Questions
TRNR details $50M pro forma annual revenue guidance, rationale of expected Sportstech acquisition, comments on market manipulation concerns and bitcoin as a Treasury asset AUSTIN, TX / ACCESS Newswire / February 27, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) (“TRNR” or the “Company”), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today […]
Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already. This season, two different genotypes of H5N1 bird flu, namely (a) the severe and lethal form D1.1 that has spread globally in […]
NanoViricides, Inc. (NYSE American:NNVC) Has Filed Its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial – Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID
SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September 30, 2024 with the Securities and Exchange Commission (SEC) on Thursday, November 14, 2024. The report can be accessed at the SEC website (https://www.sec.gov/Archives/edgar/data/1379006/000141057824001991/nnvc-20240930x10q.htm). We reported that, […]
NanoViricides (NYSE American:NNVC) to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am
SHELTON, CT / ACCESSWIRE / November 4, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President and Executive Chairman, will be presenting a corporate update at the Spartan Capital Investors Conference on Monday, November 4, 2024 (today) at 9:45 am. […]
NanoViricides (NYSE American:NNVC) President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology
SHELTON, CT / ACCESSWIRE / October 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President and Executive Chairman, was interviewed in a podcast by the PODD Conference* host. The podcast was published on October 11, 2024, on […]
Start Expanding
Your Shareholder Base
Let us help you connect with investors
committed to your success.